NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $88.34 -6.59 (-6.94%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$86.77▼$95.5450-Day Range$84.07▼$107.6452-Week Range$70.24▼$124.11Volume752,958 shsAverage Volume405,464 shsMarket Capitalization$2.75 billionP/E RatioN/ADividend YieldN/APrice Target$130.88 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get iRhythm Technologies alerts: Email Address iRhythm Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside48.1% Upside$130.88 Price TargetShort InterestBearish9.32% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.82Based on 9 Articles This WeekInsider TradingSelling Shares$294,234 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.22) to ($2.14) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.74 out of 5 starsMedical Sector465th out of 936 stocksSurgical & Medical Instruments Industry61st out of 101 stocks 4.5 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageiRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.32% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 0.69%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 3.2 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.Search Interest1 people have searched for IRTC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 3 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $294,234.00 in company stock.Percentage Held by InsidersOnly 0.68% of the stock of iRhythm Technologies is held by insiders.Read more about iRhythm Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.22) to ($2.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -20.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -20.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 12.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About iRhythm Technologies Stock (NASDAQ:IRTC)iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More IRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRTC Stock News HeadlinesJuly 4, 2024 | insidertrades.comiRhythm Technologies, Inc. (NASDAQ:IRTC) CMO Sells $148,332.60 in StockJuly 25 at 11:38 AM | finance.yahoo.comInvestors might be losing patience for iRhythm Technologies' (NASDAQ:IRTC) increasing losses, as stock sheds 3.8% over the past weekJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 25 at 4:55 AM | americanbankingnews.comiRhythm Technologies (IRTC) Set to Announce Earnings on ThursdayJuly 23 at 2:22 AM | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Recommendation of "Buy" from BrokeragesJuly 22, 2024 | investorplace.com7 Robotics Stocks That Could Grow Your WealthJuly 21, 2024 | investorplace.com3 Healthcare Stocks to Buy Now: Q3 EditionJuly 18, 2024 | globenewswire.comiRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 18, 2024 | americanbankingnews.comTruist Financial Lowers iRhythm Technologies (NASDAQ:IRTC) Price Target to $134.00June 17, 2024 | globenewswire.comiRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing AutomationJune 4, 2024 | globenewswire.comiRhythm Technologies to Present at the 2024 Truist Securities MedTech ConferenceMay 29, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Irhythm Technologies (IRTC)May 22, 2024 | globenewswire.comiRhythm Technologies to Present at the William Blair 44th Annual Growth Stock ConferenceMay 15, 2024 | money.usnews.comiRhythm Technologies IncMay 5, 2024 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its First-Quarter ReportMay 3, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)May 3, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On iRhythm TechnologiesSee More Headlines Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Target$130.88 High Stock Price Target$165.00 Low Stock Price Target$110.00 Potential Upside/Downside+41.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($4.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-25.33% Pretax Margin-25.19% Return on Equity-69.87% Return on Assets-23.50% Debt Debt-to-Equity Ratio7.13 Current Ratio7.10 Quick Ratio6.95 Sales & Book Value Annual Sales$492.68 million Price / Sales5.83 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book13.49Miscellaneous Outstanding Shares31,100,000Free Float30,893,000Market Cap$2.87 billion OptionableOptionable Beta1.24 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Quentin S. Blackford (Age 45)President, CEO & Director Comp: $2.15MMr. Brice Bobzien CPA (Age 45)Chief Financial Officer Comp: $685.12kDr. Minang P. Turakhia M.D. (Age 50)M.S., Chief Medical & Scientific Officer and Executive VP of Product Innovation Comp: $1MMr. Patrick Michael Murphy J.D. (Age 45)Chief Business & Legal Officer Comp: $1.28MMr. Douglas J. Devine (Age 54)Executive Advisor Comp: $800kMr. Chad M. Patterson (Age 42)Chief Commercial Officer Comp: $771.51kMr. Marc Rosenbaum (Age 52)Senior VP of Finance & Chief Accounting Officer Mr. Mark J. Day Ph.D. (Age 53)Chief Technology Officer Comp: $718.76kMr. Daniel G. Wilson (Age 41)Executive VP of Corporate Development & Investor Relations Comp: $670.09kMs. Sumi Shrishrimal (Age 45)Executive VP & Chief Risk Officer More ExecutivesKey CompetitorsTandem Diabetes CareNASDAQ:TNDMHaemoneticsNYSE:HAENevroNYSE:NVROPenumbraNYSE:PENBausch + LombNYSE:BLCOView All CompetitorsInsiders & InstitutionsAllspring Global Investments Holdings LLCBought 60,560 shares on 7/26/2024Ownership: 1.529%Bank of New York Mellon CorpSold 180,997 shares on 7/26/2024Ownership: 1.289%EFG Asset Management North America Corp.Bought 5,982 shares on 7/26/2024Ownership: 0.019%IMA Advisory Services Inc.Bought 5,000 shares on 7/26/2024Ownership: 0.016%Bank Pictet & Cie Europe AGSold 643 shares on 7/25/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $107.04 at the start of the year. Since then, IRTC stock has decreased by 17.5% and is now trading at $88.34. View the best growth stocks for 2024 here. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) released its earnings results on Thursday, May, 2nd. The company reported ($1.47) earnings per share for the quarter, missing the consensus estimate of ($0.99) by $0.48. The company earned $131.93 million during the quarter, compared to analyst estimates of $128.87 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 69.87% and a negative net margin of 25.33%. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional shareholders include Allspring Global Investments Holdings LLC (1.53%), Bank of New York Mellon Corp (1.29%), Assenagon Asset Management S.A. (0.16%) and Banque Pictet & Cie SA (0.13%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Daniel G Wilson, Douglas Devine, Minang Turakhia, Marc W Rosenbaum, Merz Cathleen Noel Bairey, David A Vort and Kevin M King. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD) and Advanced Micro Devices (AMD). This page (NASDAQ:IRTC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.